newsfilter
← Latest News
Business Wire·

Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, expanded its patent portfolio with the issuance of U.S. Paten